• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of inquiries resolved via IAS Action within 10 business days of date assigned during the month

Dictionary: Globalization changed FDA’s environment for regulating products. Based on the volume of imported products, FDA identified China, India, the Middle East, Europe, and Latin America as areas in which to establish a permanent presence. These foreign posts send inquiries/requests for information to FDA headquarters. The International Affairs Staff in the Office of the Center Director is responsible for responding and/or coordinating responses with technical experts to inquiries from foreign posts concerning food and cosmetic products. This measure evaluates CFSAN's timeliness in responding to these inquiries.

Fiscal Year - 2010

Skip graphic and jump to text data

TimeTargetPercentage
Oct 20097585
Nov 20097579
Dec 20097575
Jan 20107585
Feb 20107585
Mar 20107585
Apr 20107585
May 201075100
Jun 201075100
Jul 20107596
Aug 20107597
Sep 20107595

FY 2010 Overall: 85%

Number of inquiries resolved via IAS Action within 10 business days of date assigned during the month

Fiscal Year - 2010
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2009N/A85
Nov 2009N/A72
Dec 2009N/A67
Jan 2010N/A127
Feb 2010N/A105
Mar 2010N/A99
Apr 2010N/A119
May 2010N/A7
Jun 2010N/A18
Jul 2010N/A43
Aug 2010N/A37
Sep 2010N/A40

FY 2010 Total: 819

Total number of inquiries received via IAS Action during the month

Fiscal Year - 2010
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2009N/A100
Nov 2009N/A91
Dec 2009N/A89
Jan 2010N/A149
Feb 2010N/A123
Mar 2010N/A117
Apr 2010N/A140
May 2010N/A7
Jun 2010N/A18
Jul 2010N/A45
Aug 2010N/A38
Sep 2010N/A42

FY 2010 Total: 959

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.